Novel Exosome-Based Therapies for Treating Colorectal Cancer

Time: 9:00 am
day: Day One


  • T cells costimulatory functions are affected by tumor-intrinsic mechanism in colorectal cancer leading to host immune suppression
  • Modified colorectal cancer tumor EVs without immune suppressive microRNAs can stimulate antitumor immunity and has therapeutic potential in advanced disease models
  • Harnessing the immunogenicity of modified tumor EVs can be developed as a novel therapeutic strategy to reduce cancer immunotherapy resistance